Floatz logo

Ciprofloxacin

Epilepsy Intractable

Mazandaran University of Medical SciencesSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Epilepsy Intractable cohort.

Asset / SponsorPhaseRating
plt101
PhytoTech Therapeutics, Ltd.
Phase 2B
Clioquinol
KU Leuven
Phase 2CCC
Npt 2042
NeuroPro Therapeutics, Inc.
Phase 1CCC
Abi-009
Seattle Children's Hospital
Phase 1CC

Same molecule, other indications

Ciprofloxacin is also rated in:

bronchiectasisDormant
BBB
Indicative ·
76 / 100
View asset →
infectious diseaseDormant
BBB
Indicative ·
72 / 100
View asset →
chronic obstructive pulmonary diseaseDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →